Company profile

SAB Biotherapeutics, Inc. insider acquisitions

Company CIK 0001833214 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
SABS · NasdaqSABSW · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 90-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.SKYLER JAY SSKYLER JAY SPolvino William JamesPolvino William JamesLucera ErickLucera ErickEllias Helen K.Ellias Helen K.Giberson ScottGiberson ScottLink DavidLink DavidSKYLER JAY S · December 16, 2025 · Stock award · Stock Option (right to buy)Polvino William James · December 16, 2025 · Stock award · Stock Option (right to buy)Lucera Erick · December 16, 2025 · Stock award · Stock option (right to buy)Ellias Helen K. · December 16, 2025 · Stock award · Stock Option (right to buy)Giberson Scott · December 16, 2025 · Stock award · Stock Option (right to buy)Link David · December 16, 2025 · Stock award · Stock Option (right to buy)Dec 16, 2025Dec 16, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

6 dated transactions · 6 of 6 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 16, 2025SAB Biotherapeutics, Inc.Stock Option (right to buy)SKYLER JAY SStock award
Dec 16, 2025SAB Biotherapeutics, Inc.Stock Option (right to buy)Polvino William JamesStock award
Dec 16, 2025SAB Biotherapeutics, Inc.Stock option (right to buy)Lucera ErickStock award
Dec 16, 2025SAB Biotherapeutics, Inc.Stock Option (right to buy)Ellias Helen K.Stock award
Dec 16, 2025SAB Biotherapeutics, Inc.Stock Option (right to buy)Giberson ScottStock award
Dec 16, 2025SAB Biotherapeutics, Inc.Stock Option (right to buy)Link DavidStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Choose a company listing

Choose a current company listing to view its price history.

Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
SKYLER JAY SDirector
Stock awardStock Option (right to buy)Derivative security · Code A150,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (right to buy)Derivative security · Code A150,0000Value: 0Currency not specifiedView ↗
Trade:
Lucera ErickDirector
Stock awardStock option (right to buy)Derivative security · Code A150,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (right to buy)Derivative security · Code A150,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (right to buy)Derivative security · Code A150,0000Value: 0Currency not specifiedView ↗
Trade:
Link DavidDirector
Stock awardStock Option (right to buy)Derivative security · Code A150,0000Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →